Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-induced Tardive Dyskinesia”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Testing effectiveness (Phase 2)Study completedNCT02500628
What this trial is testing

Heart Rate Variability in Response to Metformin Challenge

Who this might be right for
FibromyalgiaMitochondrial DiseasesMovement Disorders+1 more
Woodinville Psychiatric Associates 61
Large-scale testing (Phase 3)Study completedNCT03176771
What this trial is testing

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Tanabe Pharma Corporation 256
Large-scale testing (Phase 3)Study completedNCT00672373
What this trial is testing

Extract of Ginkgo Biloba and Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaSchizophrenia
Beijing HuiLongGuan Hospital 157
Not applicableEnded earlyNCT00310661
What this trial is testing

Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-induced Tardive Dyskinesia
Centre for Addiction and Mental Health 60
Post-approval studies (Phase 4)Looking for participantsNCT03495024
What this trial is testing

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Who this might be right for
SchizophreniaSchizoaffective DisorderTobacco Smoking+2 more
Corporal Michael J. Crescenz VA Medical Center 10
Not applicableLooking for participantsNCT07173920
What this trial is testing

Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD

Who this might be right for
Tardive DyskinesiaRepetitive Transcranial Magnetic Stimulation
Peking University Sixth Hospital 62
Large-scale testing (Phase 3)Study completedNCT02198794
What this trial is testing

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 343
Not applicableActive Not RecruitingNCT02252380
What this trial is testing

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

Who this might be right for
Movement DisordersEssential TremorHolmes Tremor+6 more
InSightec 10
Post-approval studies (Phase 4)Study completedNCT00926965
What this trial is testing

Tardive Dyskinesia and Cognitive Function

Who this might be right for
Tardive DyskinesiaNeurocognitive Function
Taipei Veterans General Hospital, Taiwan 80
Large-scale testing (Phase 3)Study completedNCT02736955
What this trial is testing

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 161
Large-scale testing (Phase 3)Study completedNCT01543321
What this trial is testing

Xenazine in Late Dyskinetic Syndrome With Neuroleptics

Who this might be right for
Tardive Dyskinesia
Centre Hospitalier Universitaire, Amiens 54
Very early researchStudy completedNCT04794413
What this trial is testing

Pimavanserin Treatment in TS

Who this might be right for
Tourette SyndromeTardive Dyskinesia
Joseph Jankovic 10
Not applicableNot Yet RecruitingNCT06218719
What this trial is testing

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Who this might be right for
Tardive Dyskinesia
Power Life Sciences Inc. 500
Not applicableUnknownNCT03062033
What this trial is testing

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 70
Post-approval studies (Phase 4)Study completedNCT00164242
What this trial is testing

Treatment of Tardive Dyskinesia With Galantamine

Who this might be right for
Tardive Dyskinesia
Caroff, Stanley N., M.D. 36
Testing effectiveness (Phase 2)Study completedNCT00175955
What this trial is testing

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Medication-induced
UCB Pharma 70
Early research (Phase 1)Study completedNCT06216054
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects

Who this might be right for
Tardive DyskinesiaHuntington Disease
Luye Pharma Group Ltd. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365462
What this trial is testing

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 100
Post-approval studies (Phase 4)WithdrawnNCT06107829
What this trial is testing

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
Stephen Ruedrich
Testing effectiveness (Phase 2)UnknownNCT00331669
What this trial is testing

Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia

Who this might be right for
DystoniaMovement Disorder
Charite University, Berlin, Germany 24
Load More Results